In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Inc.

http://www.pfizer.com

Latest From Pfizer Inc.

Sun’s Leqvelsi Must Now Shine In Crowded JAK Inhibitor Field

The US FDA approved Leqvelsi for alopecia areata, making it the third drug in the class for the indication after Lilly’s Olumiant and Pfizer’s Litfulo.

Approvals Launches

Merck's Pneumococcal Vaccine Market Expansion Stalled By Ever-Changing, Crowded Field

The CDC’s ACIP again punted a decision on whether to make a pneumococcal vaccine available to all adults 50 and older amid concerns over cost and equity tradeoffs, as well as unknowns about the length of vaccine protection. 

Advisory Committees Vaccines

Viking Plans To Go Directly To Phase III With Obesity Drug

In its Q2 earnings call, the biotech expressed optimism about developing VK2735 as a monthly injection, with an oral version moving into Phase II. An EOP2 meeting for its MASH drug is expected in Q4.

Sales & Earnings Metabolic Disorders

Pfizer’s Hemophilia A Gene Therapy Superior To Prophylaxis In Phase III

The company’s giroctocogene fitelparvovec, partnered with Sangamo, could compete with BioMarin’s hemophilia A gene therapy Roctavian, but longer-term data may be needed.

Gene Therapy Rare Diseases
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Agouron Pharmaceuticals
    • Alpharma Pharmaceuticals LLC
    • American Home Products
    • Amplyx Pharmaceuticals, Inc.
    • Anacor Pharmaceuticals, Inc.
    • Array BioPharma, Inc. (ARRY)
    • Arixa Pharmaceuticals, Inc. Bamboo Therapeutics, Inc.
    • Bioren, Inc,
    • Coley Pharmaceutical Group, Inc.
    • CovX Pharmaceuticals, Inc
    • C.P. Pharmaceuticals International C.V.
    • Encysive Pharmaceuticals
    • Excaliard
    • FoldRx Pharmaceuticals, Inc.
    • Ferrosan Consumer Health
    • GD Searle
    • Hisun-Pfizer Pharmaceuticals Co., Ltd.
    • Hospira, Inc.
    • Icagen, Inc.
    • Idun Pharmaceuticals, Inc.
    • InnoPharma
    • Javelin Pharmaceuticals, Inc.
    • King Pharmaceuticals, Inc.
    • Lederle Laboratories
    • Mayne Pharma Limited
    • Meridica Limited
    • Neusentis
    • Parke-Davis
    • Pharmacia
    • Pharmacia and Upjohn Co.
    • PHT Pharma S.r.l.
    • Powdermed
    • Redvax GmbH
    • ReViral Ltd.
    • Serenex
    • Strato Medical Corp.
    • SUGEN
    • Texas Biothechnology Corporation
    • Thiakis Limited
    • Vicuron Pharmaceuticals
    • ViiV Healthcare
    • Warner-Lambert
    • Wyeth
    • Wyeth-Ayerst Laboratories, Inc.
    • Treerly Health Co., Ltd.
    • Meridian Medical Technologies Inc.
    • Montreal, Inc.
    • Medivation, Inc.
    • Sugen LLC
    • Therachon Holding AG.
    • Jones Pharma Inc.
    • Trillium Therapeutics Inc.
UsernamePublicRestriction

Register